Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United States

Authors

Matthew Monberg (ORCID: https://orcid.org/0009-0006-7462-4782)
J. A. Den Boer
Bradley J. Monk (ORCID: https://orcid.org/0000-0001-6985-0159)
Cumhur Tekin (ORCID: https://orcid.org/0009-0003-9579-2935)
Steve Keefe
Dominic Muston (ORCID: https://orcid.org/0000-0003-4876-7940)
Sophie van Mens
Shilpi Swami (ORCID: https://orcid.org/0000-0002-7537-8636)
Frank van Hees (ORCID: https://orcid.org/0009-0005-6156-2378)
Oliver Hale (ORCID: https://orcid.org/0000-0001-9025-751X)

Institutions

Creighton University (US)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
University of Arizona (US)
HonorHealth (US)

Publication Details

Journal: Oncology and Therapy
Published: 2024-11-05
DOI: https://doi.org/10.1007/s40487-024-00311-5
Citations: 7
Primary Topic: Economic and Financial Impacts of Cancer
Type: article
Field-Weighted Citation Impact: 7.90

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United States

Matthew Monberg, J. A. Den Boer, Bradley J. Monk, Cumhur Tekin et al.

Nov 5, 2024

7 citations

Oncology and Therapy

Economic and Financial Impacts of Cancer

7.90

article

Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United States

Matthew Monberg, J. A. Den Boer, Bradley J. Monk, Cumhur Tekin, Steve Keefe, Dominic Muston, Sophie van Mens, Shilpi Swami, Frank van Hees, Oliver Hale

November 5, 2024article en

7 citations

Abstract

No abstract available for this paper.

Oncology and TherapyVol. 13(1)

Creighton University (US), Merck & Co., Inc., Rahway, NJ, USA (United States) (US), University of Arizona (US), HonorHealth (US)

Good health and well-being

Openalex Percentile: Top 3%

Economic and Financial Impacts of Cancer

7.90

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.